The Olympus scanR High-Content Screening Station Rapidly Acquires Quantitative Data from Cell-Based Assays

Self-learning microscopy opens new horizons in high-content analysis and advances phenotypic screening

Olympus announces the US launch of the scanR high-content screening (HCS) station, a cell imaging solution that utilizes artificial intelligence (AI) to enable next-generation biological research. It combines the modularity and flexibility of a microscope-based setup with the automation, speed, throughput and reproducibility of an HCS station.

AI Meets High-Content Screening

The Olympus scanR HCS station uses the power of AI to carry out groundbreaking analyses of cells that, until recently, seemed impossible to do. Olympus’ self-learning microscopy technology reduces photobleaching and improves acquisition speed, measurement sensitivity, and accuracy, facilitating longer observations with reduced influence on cell viability.

The Power of Deep Learning

The system acquires pairs of images that are processed by the software to generate an image analysis model. Olympus’ optimized deep-learning technology, which is based on a dedicated convolutional neural network architecture, provides powerful and flexible learned analysis protocols. No human data annotations are required, which allows large numbers of examples to be used, enabling the potential of the deep-learning technology to be fully exploited.

Self-Learning Microscopy

After a one-time training phase, scanR AI enables the system to automatically analyze new data by incorporating the learned analysis protocol into its assay-based workflow. Because the user has full control in designing the training experiment and many challenging analysis conditions can be covered during the training phase, the accuracy and robustness of the analysis results are improved.

Robust, Fast and Automated Image Acquisition and Analysis

The scanR system performs fully automated image acquisition and analysis of multiwell plates, slides and custom-built arrays. Throughout the automated image acquisition, the scanR system maintains the focus plane using a combination of software algorithms and hardware, including TruFocus Z-drift compensation. Images are automatically analyzed during acquisition to minimize analysis time, and all units are precisely synchronized by a real-time controller to maximize the acquisition speed.

Simple Workflow and Fast Setup to Ease Research

The scanR HCS station combines these benefits with a user-friendly workflow that requires less human interaction, even during the AI training stage. The responsive interface contributes to intuitive, straightforward analysis. This makes it easy for life science and pharmaceutical researchers to harness the power of HCS data while benefitting from a fast, simple setup.

For more information, please visit olympus-lifescience.com/microscopes/inverted/scanr/

About Olympus

Olympus is a global technology leader, crafting innovative optical and digital solutions in medical technologies; life sciences; industrial solutions; and cameras and audio products. Throughout our 100-year history, Olympus has focused on being true to society and making people’s lives healthier, safer and more fulfilling.

Our Life Sciences Business is dedicated to meeting and exceeding the evolving needs and expectations of life science professionals through a comprehensive range of clinical, educational and research microscopes and microscope systems. For more information, visit https://www.olympus-lifescience.com and truetolife.com.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Evident Corporation - Life Sciences. (2019, December 06). The Olympus scanR High-Content Screening Station Rapidly Acquires Quantitative Data from Cell-Based Assays. News-Medical. Retrieved on November 23, 2024 from https://www.news-medical.net/news/20191206/The-Olympus-scanR-High-Content-Screening-Station-Rapidly-Acquires-Quantitative-Data-from-Cell-Based-Assays.aspx.

  • MLA

    Evident Corporation - Life Sciences. "The Olympus scanR High-Content Screening Station Rapidly Acquires Quantitative Data from Cell-Based Assays". News-Medical. 23 November 2024. <https://www.news-medical.net/news/20191206/The-Olympus-scanR-High-Content-Screening-Station-Rapidly-Acquires-Quantitative-Data-from-Cell-Based-Assays.aspx>.

  • Chicago

    Evident Corporation - Life Sciences. "The Olympus scanR High-Content Screening Station Rapidly Acquires Quantitative Data from Cell-Based Assays". News-Medical. https://www.news-medical.net/news/20191206/The-Olympus-scanR-High-Content-Screening-Station-Rapidly-Acquires-Quantitative-Data-from-Cell-Based-Assays.aspx. (accessed November 23, 2024).

  • Harvard

    Evident Corporation - Life Sciences. 2019. The Olympus scanR High-Content Screening Station Rapidly Acquires Quantitative Data from Cell-Based Assays. News-Medical, viewed 23 November 2024, https://www.news-medical.net/news/20191206/The-Olympus-scanR-High-Content-Screening-Station-Rapidly-Acquires-Quantitative-Data-from-Cell-Based-Assays.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Olympus Discovery Center inaugurated at the University of Maryland